The Direct Answer: Free vs Total Testosterone
Free testosterone and total testosterone answer related but different questions. Total testosterone measures the overall amount of testosterone in a blood sample, including testosterone bound to sex hormone-binding globulin, abbreviated SHBG, albumin, and other circulating proteins. Free testosterone measures the small fraction that is not protein-bound and is therefore considered more directly available to tissues. Neither result is automatically “better”: total testosterone is often the main screening test, while calculated or directly measured free testosterone can help when SHBG is unusually high or low. The most useful interpretation usually combines both results with symptoms, the time of the blood draw, the laboratory method, and repeat testing. As of September 2026, no single testosterone threshold diagnoses a health problem in every adult.
Also worth reading: What Are the Normal Steroid Hormone Test Thresholds for Testosterone in 2026? · I’m 16 With Low Testosterone—What Should I Do Next? · Is Testosterone Safe for Teens, and What Should Parents Know About Using It Without a Medical Indication?
A common source of confusion is that the same laboratory can report total testosterone as roughly 300 ng/dL and free testosterone as only 6 ng/dL. Those numbers are not directly comparable because their units and biological meanings differ. The reference ranges also vary by laboratory, assay, sex, age, and the method used to estimate free testosterone. A clinician should not compare a free testosterone result with the reference range printed for total testosterone. The practical priority is to determine why a result is abnormal, rather than focusing on whether the word “free” appears beside the number.
How Free and Total Testosterone Differ
Around 95% to 98% of circulating testosterone in men is bound to SHBG or albumin, while only about 1% to 3% circulates unbound. SHBG binds testosterone with greater affinity than albumin, which means a change in SHBG can substantially alter the free fraction without a comparable change in total testosterone. If SHBG rises, total testosterone may remain steady while free testosterone falls. If SHBG falls, free testosterone may increase even when total testosterone appears unchanged. This relationship explains why two people with the same total testosterone level can have different estimated free testosterone concentrations.
Free testosterone is sometimes measured directly, although many laboratories calculate it from total testosterone, SHBG, and albumin. Calculation methods are not interchangeable. The method based on total testosterone, SHBG, and albumin is widely used, but it can become less reliable when SHBG is very high, very low, or outside the range in which the calculation was validated. Direct equilibrium dialysis or ultrafiltration may offer a more specific measurement, but availability, cost, and turnaround time vary. Asking the laboratory which approach it used can be as important as knowing the reported number.
| Feature | Total Testosterone | Free Testosterone |
|---|---|---|
| What it measures | All circulating testosterone, bound and unbound | The unbound fraction considered available to tissues |
| Common clinical role | Usual first-line screening test | Useful follow-up when SHBG affects interpretation |
| Main influence | Production, metabolism, SHBG, and binding | Binding and SHBG; production also matters |
| Main weakness | Can mislead when SHBG is high or low | Depends on a reliable method and clinical context |
| Units commonly reported | ng/dL in the United States | pg/mL, ng/dL, or nmol/L depending on the assay |
| Example adult male context | Reference ranges often fall near 300–1,000 ng/dL, but assay-specific ranges matter | Interpret only against the laboratory’s own range and method |
SHBG is produced mainly by the liver and is influenced by hormones, liver function, body composition, age, and several medical conditions. High SHBG is more common with older age, hyperthyroidism, liver disease, certain genetic conditions, and use of estrogens. It may also occur in people taking some anticonvulsants. Low SHBG can be associated with obesity, insulin resistance, type 2 diabetes, high insulin, Cushing syndrome, or use of androgens. These associations do not prove that SHBG itself caused a symptom, and broad screening for every person with an unexpected testosterone result is not automatically required.
Consider a hypothetical example. A man has total testosterone of 400 ng/dL, which may appear comfortably within his laboratory’s range, but his SHBG is elevated at 70 nmol/L. A calculation based on total testosterone, SHBG, and albumin might produce an estimated free testosterone near 5 pg/mL, potentially below the laboratory’s lower limit. Another man with the same 400 ng/dL total testosterone but lower SHBG may have an estimated free testosterone near 10 pg/mL. Without SHBG, the first result can be misread as reassuring even when bioavailable availability appears reduced.
A high total testosterone with elevated SHBG can occur in some hyperthyroid or liver-related states, while a low total testosterone with suppressed SHBG can occur in obesity or uncontrolled diabetes. Neither pattern should be turned directly into a treatment decision. The clinician should evaluate the underlying condition, review medications, consider signs of excess androgen activity, and decide whether free testosterone would change management. The value of adding a free testosterone assay is greatest when symptoms and total testosterone do not align.
Reference Ranges, Units, and the Problem With One Cutoff
Laboratories provide reference intervals, but these are distributions observed in a selected population, not boundaries separating “normal” from “diseased.” Many US laboratories use a total testosterone reference range for adult men of approximately 300–1,000 ng/dL, while others center the interval around 450–600 ng/dL. Free testosterone may be reported in pg/mL, ng/dL, or nmol/L, and a result such as 7 ng/dL can be numerically similar to 7 pg/mL while representing a very different concentration. Always check the unit and the range attached to that specific assay.
There is no universal free testosterone cutoff that works for laboratories, measurement techniques, and clinical purposes. Some clinicians treat a clearly low result on repeat morning testing as a reason to investigate, particularly when it is accompanied by symptoms such as reduced libido, impaired erectile function, decreased energy, reduced muscle mass, or loss of body hair. Others place more weight on a trajectory from the individual’s previous results. A mildly low value without compatible symptoms is less likely to justify immediate treatment than a substantially low result with persistent symptoms and normal causes of suppression excluded.
Conversion errors are especially easy when comparing online calculators with laboratory reports. The formulas may assume sex, reference range, units, or a particular binding constant that does not match the assay. To convert concentrations accurately, 1 ng/dL of testosterone equals approximately 0.0347 nmol/L, while 1 ng/mL equals 100 ng/dL. A number can therefore look precise while being interpreted in the wrong unit system. The safest comparison is the original laboratory report, including its units, reference interval, collection time, and analytical method.
How to Test Testosterone Without Confusing a Temporary Change
For people whose bodies produce testosterone primarily through testicular or ovarian pathways, the standard approach is an early-morning sample, usually between 7:00 and 10:00 a.m., when concentrations are highest. Evening measurements can be substantially lower and may lead to an unnecessary diagnosis. Total testosterone should usually be measured first, and a free testosterone estimate is most useful if total testosterone is unexpectedly low or borderline or if symptoms suggest a mismatch. For people taking testosterone, timing of the blood draw relative to the dose or injection can strongly affect the result.
A low total testosterone should generally be confirmed with a second morning sample before starting treatment. Testing during an acute illness, severe sleep deprivation, prolonged fasting, or major physical stress can produce a temporarily reduced value. The person should tell the clinician about recent illness, weight changes, new medications, supplements, fertility treatments, and testosterone exposure. The laboratory should also be asked to note acute or chronic use of glucocorticoids, opioids, some progestins, finasteride, dutasteride, and certain other drugs. A high total testosterone may be repeated if there is poor labeling, no supporting symptoms, or concern about assay interference.
Testing is not appropriate as a stand-alone internet screening tool. A symptom quiz or calculator cannot determine whether a measurement is reliable or whether a person needs evaluation. AI can help organize symptoms, explain laboratory reports, identify missing information, and suggest questions for a clinician, but it cannot physically confirm a diagnosis or replace laboratory confirmation. The strongest workflow is symptom review followed by appropriately timed testing, followed by human clinical interpretation when results are abnormal or treatment is being considered.
Symptoms, Diagnosis, and When the Two Tests Disagree
Low testosterone is a clinical evaluation, not a diagnosis based on one laboratory number. In men, health professionals may consider reduced libido, sexual dysfunction, decreased energy, mood changes, reduced muscle strength, increased body fat, infertility, gynecomastia, or reduced body hair. Some symptoms are nonspecific and can also result from sleep apnea, depression, thyroid disease, anemia, medication effects, poor nutrition, or excessive training. A person can have a total testosterone result within range and still experience symptoms because free testosterone, SHBG, or a nonhormonal condition may be relevant.
When total and free testosterone disagree, the disagreement becomes clinically useful only after several questions are answered. Is the result below or above the assay’s range? Was the blood taken in the morning? Did the person use testosterone, strongyrogens, antiandrogens, or medicines that alter SHBG? Are there compatible symptoms? Has the result been repeated? If the answers are unclear, the result should not trigger a medication order. If symptoms are strong, the pattern persists, and the measurements are confirmed, a clinician may evaluate pituitary, thyroid, liver, metabolic, sleep, or medication-related contributors.
Some commercial laboratories use direct immunoassays for total testosterone that perform inadequately at the very low end, although modern methods have improved the problem. A large US study reported that nearly 11% of samples sent for testosterone testing were misclassified in one comparison involving older direct-assay methods and a newer method. The exact percentage should not be applied to every current assay or laboratory, but it shows why assay quality matters. At very low or very high concentrations, dilution or mass spectrometry may be needed, and repeating the test in a different laboratory can be informative.
Treatment Options and Why Numbers Are Not the Only Decision
Testosterone replacement may improve selected outcomes in appropriately diagnosed men with low testosterone and compatible symptoms, but it is not automatically the best response to fatigue, low libido, or reduced exercise performance. Treatment decisions depend on symptoms, repeated concentrations, fertility goals, prostate and cardiovascular history, sleep apnea risk, hematocrit, and patient preference. Testosterone therapy can suppress sperm production, reduce testicular size, worsen untreated severe sleep apnea, increase hematocrit, cause acne, and have other effects. These risks do not mean treatment is ineffective; they mean it should not be prescribed from a single total or free testosterone value.
Alternatives may be more suitable when the main issue is not inadequate testosterone production. Treating sleep apnea, depression, iron deficiency, thyroid disease, obesity, or a medication effect can address the actual problem. Clomiphene and hCG are sometimes considered when fertility must be preserved, while treating an underlying condition such as obesity or hyperthyroidism may alter SHBG and testosterone availability. Enclomifene is another prescription option in some settings; research describes it as increasing total and free testosterone without disproportionately increasing dihydrotestosterone, but it is not appropriate for everyone. Fertility, prostate symptoms, liver function, and personal contraindications must be considered with any option.
Lifestyle changes should not be framed as guaranteed testosterone restoration. Resistance training, adequate sleep, sustainable weight loss, adequate energy intake, and review of medications can improve overall health, yet their effects vary. Research has found lower basal total and free testosterone among some exercisers than sedentary comparison groups, which is not evidence that exercise causes clinically important androgen deficiency. Low-fat diets have also been associated with lower total and free testosterone in some studies, and proposed explanations include changes in testicular synthesis, energy intake, or confounding. A restrictive diet should not be used deliberately to lower testosterone without clinical guidance.
Cost, Access, and a Practical Testing Plan
Cost varies by country, insurance plan, laboratory, and whether a prescription is required. In the United States, an independently ordered total testosterone blood test may cost roughly $30 to $100 before fees such as phlebotomy, while a more comprehensive panel, direct free testosterone measurement, or SHBG test may cost about $50 to $250 or more. Insurance-covered testing is often less expensive when ordered by a clinician, although copays and prior authorization vary. Direct free testosterone testing by equilibrium dialysis can cost several hundred dollars and may be more expensive than calculated free testosterone. Prices change, so the laboratory’s current quote is more reliable than an online estimate.
A practical first step is to review existing results for total testosterone, units, reference range, collection time, and the laboratory comments. If the result is low and symptoms are compatible, schedule a repeat early-morning total testosterone test and discuss adding SHBG with calculated free testosterone. Bring a medication and supplement list, document symptom duration, and record recent acute illness, fasting, or unusually strenuous exercise. Obtain insurance coverage information before ordering a specialized assay. If a result is borderline rather than clearly abnormal, saving money by repeating the correct test may be more useful than buying a large hormone panel immediately.
As an AI Healthcare Benefits Consultant-style resource, the focus is not to sell treatment but to help a person ask the right questions, understand possible costs, and decide when professional care is warranted. Free versus total testosterone cannot be settled by a branded calculator, supplement bundle, or clinic slogan. The best information is a correctly timed result, the correct units, an appropriate free testosterone method when needed, and clinical assessment of the whole person. That approach reduces false reassurance, unnecessary treatment, and avoidable out-of-pocket spending.
The Bottom Line for Patients and Clinicians
Total testosterone is generally the practical starting point because it measures the full circulating pool and is commonly used for initial screening. Free testosterone becomes more informative when SHBG is abnormal, symptoms and total testosterone conflict, or the result needs a second look. A total testosterone value near 400 ng/dL cannot be judged without units, timing, symptoms, and the laboratory range, and neither a total nor a free result stands alone as a diagnosis. The free fraction is only about 1% to 3% of circulating testosterone, but it is not merely a small irrelevant number; binding to SHBG changes how much is available.
The most defensible next move is not to choose whichever result is lower. It is to confirm that the measurement was valid and obtained at an appropriate time, then interpret total testosterone, SHBG, free testosterone, symptoms, medications, and medical history together. Repeated low measurements with compatible symptoms may justify evaluation, while an isolated low value during illness, at night, or after certain drugs may not. Anyone considering testosterone therapy should discuss fertility, prostate risk, sleep apnea, hematocrit, alternatives, and monitoring before deciding. A clinician can also prevent errors involving units, assay methods, and conflicting online reference ranges.